BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 24046120)

  • 1. Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.
    Takahashi Y; Iwaya T; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Takano Y; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Ann Surg Oncol; 2014 Jan; 21(1):205-12. PubMed ID: 24046120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
    Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
    Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
    Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
    Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer.
    Sakimura S; Sugimachi K; Kurashige J; Ueda M; Hirata H; Nambara S; Komatsu H; Saito T; Takano Y; Uchi R; Sakimura E; Shinden Y; Iguchi T; Eguchi H; Oba Y; Hoka S; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1436-43. PubMed ID: 25707493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
    Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
    Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
    Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
    Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
    Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
    Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
    Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
    Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
    Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
    Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X
    Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.
    Hur K; Toiyama Y; Okugawa Y; Ide S; Imaoka H; Boland CR; Goel A
    Gut; 2017 Apr; 66(4):654-665. PubMed ID: 26701878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-29b is a Novel Prognostic Marker in Colorectal Cancer.
    Inoue A; Yamamoto H; Uemura M; Nishimura J; Hata T; Takemasa I; Ikenaga M; Ikeda M; Murata K; Mizushima T; Doki Y; Mori M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1410-8. PubMed ID: 25472644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer.
    Shibuya H; Iinuma H; Shimada R; Horiuchi A; Watanabe T
    Oncology; 2010; 79(3-4):313-20. PubMed ID: 21412018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
    Lian J; Jing Y; Dong Q; Huan L; Chen D; Bao C; Wang Q; Zhao F; Li J; Yao M; Qin L; Liang L; He X
    Oncotarget; 2016 Jan; 7(3):2672-83. PubMed ID: 26684241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.
    Takahashi Y; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Ishibashi M; Takano Y; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Anticancer Res; 2013 May; 33(5):1927-34. PubMed ID: 23645740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the Nek2 kinase in colorectal cancer correlates with beta-catenin relocalization and shortened cancer-specific survival.
    Neal CP; Fry AM; Moreman C; McGregor A; Garcea G; Berry DP; Manson MM
    J Surg Oncol; 2014 Dec; 110(7):828-38. PubMed ID: 25043295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
    Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-33b inhibits tumor cell growth and is associated with prognosis in colorectal cancer patients.
    Liao W; Gu C; Huang A; Yao J; Sun R
    Clin Transl Oncol; 2016 May; 18(5):449-56. PubMed ID: 26329295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
    Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
    Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.